RadNet (NASDAQ:RDNT – Get Free Report) is projected to post its quarterly earnings results before the market opens on Friday, February 28th. Analysts expect RadNet to post earnings of $0.21 per share and revenue of $459.42 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
RadNet Price Performance
Shares of RadNet stock opened at $59.67 on Wednesday. The business has a 50 day simple moving average of $66.64 and a two-hundred day simple moving average of $69.22. RadNet has a 12 month low of $36.47 and a 12 month high of $93.65. The stock has a market capitalization of $4.42 billion, a P/E ratio of -852.31 and a beta of 1.79. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.16 and a quick ratio of 2.16.
Analysts Set New Price Targets
A number of equities analysts have commented on the company. Jefferies Financial Group reduced their target price on RadNet from $100.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, January 15th. Barclays reduced their target price on RadNet from $85.00 to $74.00 and set an “overweight” rating for the company in a report on Wednesday, January 22nd. Finally, Truist Financial reissued a “buy” rating and set a $88.00 target price (down previously from $94.00) on shares of RadNet in a report on Wednesday, January 22nd. One investment analyst has rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, RadNet presently has a consensus rating of “Moderate Buy” and an average price target of $75.50.
RadNet Company Profile
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
See Also
- Five stocks we like better than RadNet
- What is the Nasdaq? Complete Overview with History
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- EV Stocks and How to Profit from Them
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What is the NASDAQ Stock Exchange?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.